Search

14 results for “switch over”

• Review ArticleOpen Access

  Switch over from intravenous to oral therapy: A concise overview

  Jissa Maria Cyriac, Emmanuel James

  Vol. 5 · Issue 2 · pp. 83–87

  https://doi.org/10.4103/0976-500X.130042
  Full text ↗PDF

• Case ReportOpen Access

  Recurrence of atrial fibrillation after switching from brand to generic atenolol

  Luca Gallelli, Francesca Maida, Orietta Staltari, Pierandrea Rende, Emilio Russo, Benedetto Caroleo

  Vol. 5 · Issue 1 · pp. 158–160

  https://doi.org/10.4103/0976-500X.149146
  Full text ↗PDF

• Research LetterOpen Access

  Physician Preferences for Olanzapine Standard Oral Tablets and Orally Disintegrating Tablets: A Cross-Sectional Survey

  Hardik Gandhi

  Vol. 13 · Issue 1 · pp. 97–98

  https://doi.org/10.1177/0976500X221080392
  Full text ↗PDF

• Case ReportOpen Access

  Pharmaceutical Care in Patients with Side Effects to Oral Antineoplastic Agents: A Case Report

  Teresa Chinchilla-Alarcon, Belen Maria Muñoz-Cejudo, Maria Antonia Mora-Mora

  Vol. 15 · Issue 4 · pp. 427–430

  https://doi.org/10.1177/0976500X241283125
  Full text ↗PDF

• Research PaperOpen Access

  Three‑way, three‑period, crossover bioequivalence study of single oral dose of three brands of 300 mg phenytoin sodium tablets marketed in India, on healthy Indian human volunteers

  Maulik S. Doshi, Anuja A. Naik, Mohit R. Mehta, Nithya J. Gogtay, Urmila M. Thatte, Mala D. Menon

  Vol. 4 · Issue 4 · pp. 243–246

  https://doi.org/10.4103/0976-500X.119709
  Full text ↗PDF

• Research PaperOpen Access

  Comparative Effect of Divided Doses of Adult Solid and Liquid Oral Formulations of Antiepileptic Drugs in the Management of Pediatric Epilepsy

  Ravi Prasad Nidanapu, Bascarane Tamijarassy, Subramanian Mahadevan, Batmanabane Gitanjali

  Vol. 8 · Issue 2 · pp. 54–61

  https://doi.org/10.4103/jpp.JPP_7_17
  Full text ↗PDF

• Review ArticleOpen Access

  L-asparaginase in the treatment of patients with acute lymphoblastic leukemia

  Rachel A. Egler, Sanjay P. Ahuja, Yousif Matloub

  Vol. 7 · Issue 2 · pp. 62–71

  https://doi.org/10.4103/0976-500X.184769
  Full text ↗PDF

• EditorialOpen Access

  The three Rs of written assessment: The JIPMER experience

  Manikandan S, Gitanjali B

  Vol. 7 · Issue 3 · pp. 115–116

  https://doi.org/10.4103/0976-500X.189650
  Full text ↗PDF

• Case ReportOpen Access

  Skin rash during treatment with generic itraconazole

  Antonio De Vuono, Caterina Palleria, Francesca Scicchitano, Aida Squillace, Giovambattista De Sarro, Luca Gallelli

  Vol. 5 · Issue 2 · pp. 158–160

  https://doi.org/10.4103/0976-500X.130086
  Full text ↗PDF

• Case ReportOpen Access

  Risperidone‑induced mania: An emergent complication of treatment

  Anjana Rao Kavoor, Sayantanava Mitra, Supriya Kumar Mondal, Basudeb Das

  Vol. 5 · Issue 4 · pp. 258–260

  https://doi.org/10.4103/0976-500X.142448
  Full text ↗PDF

• Case SeriesOpen Access

  Safety and efficacy of generic drugs with respect to brand formulation

  Luca Gallelli, Caterina Palleria, Antonio Vuono, Laura Mumoli, Piero Vasapollo, Brunella Piro, Emilio Russo

  Vol. 4 · pp. S110–S111

  https://doi.org/10.4103/0976-500X.120972
  Full text ↗PDF

• News and ViewsOpen Access

  Ketamine for fast alleviation of acute depression

  G. Sivagnanam

  Vol. 3 · pp. 210–210

  Full text ↗PDF

• Case ReportOpen Access

  Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction

  Ashish P. Anovadiya, Manish J. Barvaliya, Tejas K. Patel, C. B. Tripathi

  Vol. 2 · Issue 3 · pp. 187–188

  https://doi.org/10.4103/0976-500X.83285
  Full text ↗PDF

• Educational ForumOpen Access

  Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

  Darshan J. Dave

  Vol. 2 · Issue 4 · pp. 230–235

  https://doi.org/10.4103/0976-500X.85934
  Full text ↗PDF